Ancient fungus takes on recurrent lung infection in new trial

NCT ID NCT07174076

Recruiting now Prevention Sponsor: Bin Cao Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 29 times

Summary

This study tests whether a daily capsule made from cordyceps sinensis, a type of fungus, can stop a serious lung infection (MAC lung disease) from returning in adults who have already been cured. Three hundred participants will take either the cordyceps capsule or a placebo for 12 months, with regular checkups every 3 months. The goal is to see if this natural supplement can prevent bacterial recurrence and reduce the need for future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anhui Chest Hospital
RECRUITING

Hefei, Anhui, China
Beijing Chest Hospital, Capital Medical University
NOT_YET_RECRUITING

Beijing, Beijing Municipality, China
China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, China
Guangzhou Chest Hospital
NOT_YET_RECRUITING

Guangzhou, Guangdong, China
Jiangxi Chest Hospital
RECRUITING

Nanchang, Jiangxi, China
Shanghai Pulmonary Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China

Conditions

Explore the condition pages connected to this study.

MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE